Birla Precision Technologies Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 12:31 am

Competitors of Birla Precision Technologies Ltd

All Competitor Stocks of Birla Precision Technologies Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:41 am

Below is a detailed analysis of the quarterly data for Birla Precision Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 52.50 Cr.. The value appears to be declining and may need further review. It has decreased from 53.33 Cr. (Dec 2024) to 52.50 Cr., marking a decrease of 0.83 Cr..
• For Expenses, as of Mar 2025, the value is 46.65 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 50.08 Cr. (Dec 2024) to 46.65 Cr., marking a decrease of 3.43 Cr..
• For Operating Profit, as of Mar 2025, the value is 5.85 Cr.. The value appears strong and on an upward trend. It has increased from 3.25 Cr. (Dec 2024) to 5.85 Cr., marking an increase of 2.60 Cr..
• For OPM %, as of Mar 2025, the value is 11.14%. The value appears strong and on an upward trend. It has increased from 6.09% (Dec 2024) to 11.14%, marking an increase of 5.05%.
• For Other Income, as of Mar 2025, the value is 1.03 Cr.. The value appears strong and on an upward trend. It has increased from 0.30 Cr. (Dec 2024) to 1.03 Cr., marking an increase of 0.73 Cr..
• For Interest, as of Mar 2025, the value is 1.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.44 Cr. (Dec 2024) to 1.88 Cr., marking an increase of 0.44 Cr..
• For Depreciation, as of Mar 2025, the value is 0.86 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.58 Cr. (Dec 2024) to 0.86 Cr., marking a decrease of 0.72 Cr..
• For Profit before tax, as of Mar 2025, the value is 4.14 Cr.. The value appears strong and on an upward trend. It has increased from 0.53 Cr. (Dec 2024) to 4.14 Cr., marking an increase of 3.61 Cr..
• For Tax %, as of Mar 2025, the value is 18.12%. The value appears to be improving (decreasing) as expected. It has decreased from 150.94% (Dec 2024) to 18.12%, marking a decrease of 132.82%.
• For Net Profit, as of Mar 2025, the value is 3.38 Cr.. The value appears strong and on an upward trend. It has increased from -0.26 Cr. (Dec 2024) to 3.38 Cr., marking an increase of 3.64 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.51. The value appears strong and on an upward trend. It has increased from -0.04 (Dec 2024) to 0.51, marking an increase of 0.55.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:30 pm

Growth

Last Updated: September 5, 2025, 2:41 pm

Balance Sheet

Last Updated: July 25, 2025, 1:41 pm

Below is a detailed analysis of the balance sheet data for Birla Precision Technologies Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 146.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2024) to 146.00 Cr., marking an increase of 6.00 Cr..
• For Borrowings, as of Mar 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 44.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 64.00 Cr.. The value appears to be improving (decreasing). It has decreased from 73.00 Cr. (Mar 2024) to 64.00 Cr., marking a decrease of 9.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 279.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 270.00 Cr. (Mar 2024) to 279.00 Cr., marking an increase of 9.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 61.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Mar 2024) to 61.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 9.00 Cr..
• For Other Assets, as of Mar 2025, the value is 188.00 Cr.. The value appears to be declining and may need further review. It has decreased from 191.00 Cr. (Mar 2024) to 188.00 Cr., marking a decrease of 3.00 Cr..
• For Total Assets, as of Mar 2025, the value is 279.00 Cr.. The value appears strong and on an upward trend. It has increased from 270.00 Cr. (Mar 2024) to 279.00 Cr., marking an increase of 9.00 Cr..

Notably, the Reserves (146.00 Cr.) exceed the Borrowings (56.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Birla Precision Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 5. It has decreased from 1.43 (Mar 24) to 0.89, marking a decrease of 0.54.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 5. It has decreased from 1.43 (Mar 24) to 0.89, marking a decrease of 0.54.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.88. This value is below the healthy minimum of 3. It has decreased from 2.41 (Mar 24) to 1.88, marking a decrease of 0.53.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.77. It has increased from 22.84 (Mar 24) to 23.77, marking an increase of 0.93.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.77. It has increased from 22.84 (Mar 24) to 23.77, marking an increase of 0.93.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 32.36. It has decreased from 34.18 (Mar 24) to 32.36, marking a decrease of 1.82.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 3.15. This value is within the healthy range. It has decreased from 4.06 (Mar 24) to 3.15, marking a decrease of 0.91.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.15. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 2.15, marking a decrease of 0.92.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.28. This value is within the healthy range. It has decreased from 2.54 (Mar 24) to 1.28, marking a decrease of 1.26.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 2. It has decreased from 1.43 (Mar 24) to 0.88, marking a decrease of 0.55.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 2. It has decreased from 1.43 (Mar 24) to 0.88, marking a decrease of 0.55.
• For PBDIT Margin (%), as of Mar 25, the value is 9.71. This value is below the healthy minimum of 10. It has decreased from 11.87 (Mar 24) to 9.71, marking a decrease of 2.16.
• For PBIT Margin (%), as of Mar 25, the value is 6.63. This value is below the healthy minimum of 10. It has decreased from 8.99 (Mar 24) to 6.63, marking a decrease of 2.36.
• For PBT Margin (%), as of Mar 25, the value is 3.95. This value is below the healthy minimum of 10. It has decreased from 7.44 (Mar 24) to 3.95, marking a decrease of 3.49.
• For Net Profit Margin (%), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 5. It has decreased from 4.18 (Mar 24) to 2.73, marking a decrease of 1.45.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 8. It has decreased from 4.18 (Mar 24) to 2.73, marking a decrease of 1.45.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.73. This value is below the healthy minimum of 15. It has decreased from 6.26 (Mar 24) to 3.73, marking a decrease of 2.53.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.48. This value is below the healthy minimum of 10. It has decreased from 13.02 (Mar 24) to 8.48, marking a decrease of 4.54.
• For Return On Assets (%), as of Mar 25, the value is 2.11. This value is below the healthy minimum of 5. It has decreased from 3.52 (Mar 24) to 2.11, marking a decrease of 1.41.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.35. This value is within the healthy range. It has increased from 0.29 (Mar 24) to 0.35, marking an increase of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 0.89 (Mar 24) to 0.78, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.69. This value is within the healthy range. It has increased from 1.68 (Mar 24) to 1.69, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has increased from 1.11 (Mar 24) to 1.16, marking an increase of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 4. It has decreased from 0.90 (Mar 24) to 0.86, marking a decrease of 0.04.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.46 (Mar 24) to 0.00, marking a decrease of 3.46.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 2.04 (Mar 24) to 0.00, marking a decrease of 2.04.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.54 (Mar 24) to 0.00, marking a decrease of 96.54.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 97.96 (Mar 24) to 0.00, marking a decrease of 97.96.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.63. This value is within the healthy range. It has decreased from 7.65 (Mar 24) to 3.63, marking a decrease of 4.02.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.02. This value is below the healthy minimum of 3. It has decreased from 3.69 (Mar 24) to 2.02, marking a decrease of 1.67.
• For Enterprise Value (Cr.), as of Mar 25, the value is 272.84. It has decreased from 410.05 (Mar 24) to 272.84, marking a decrease of 137.21.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has decreased from 1.82 (Mar 24) to 1.28, marking a decrease of 0.54.
• For EV / EBITDA (X), as of Mar 25, the value is 13.15. This value is within the healthy range. It has decreased from 15.31 (Mar 24) to 13.15, marking a decrease of 2.16.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.73 (Mar 24) to 1.11, marking a decrease of 0.62.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 96.53 (Mar 24) to 0.00, marking a decrease of 96.53.
• For Price / BV (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.60 (Mar 24) to 1.51, marking a decrease of 1.09.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.73 (Mar 24) to 1.11, marking a decrease of 0.62.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness